HAE — HAEMONETICS CORP

Ownership history in Man Group plc  ·  30 quarters on record

This page tracks every 13F SEC filing in which Man Group plc reported a position in HAEMONETICS CORP (HAE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.29% (2018 Q3)
Avg. % of fund
0.05%
First filed
2018 Q1
Last filed
2025 Q3
Quarters held
30
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 503,120 +341,300 +210.9% 0.04% $24.5M $48.74
2025 Q2 ADDED 161,820 +158,722 +5123.4% 0.02% $12.1M $74.61
2024 Q4 REDUCED 3,098 -21,511 -87.4% 0.00% $242K $78.08
2024 Q3 ADDED 24,609 +4,669 +23.4% 0.01% $2.0M $80.38
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    HAE price (monthly, adj. close)

Other funds also holding HAE

As of 2025 Q4 — sorted by position size

North Peak Capital Management, LLC 3Y 7Y 7.51% KESTREL INVESTMENT MANAGEMENT CORP 3Y 7Y 4.46% QSV Equity Investors LLC 1.66% Aristotle Capital Boston, LLC 3Y 7Y 1.63% Sio Capital Management, LLC 3Y 7Y 1.17% BEACON INVESTMENT ADVISORS LLC 3Y 1.02% River Road Asset Management, LLC 3Y 7Y 0.97% Riverwater Partners LLC 3Y 0.96% ISTHMUS PARTNERS, LLC 3Y 7Y 0.6% MIZUHO MARKETS AMERICAS LLC 3Y 0.43%
← Back to Man Group plc Holdings